2016 Digestive Disease Week

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Samir Gupta, MD, Associate Professor of Medicine at the University of California San Diego, who has led trials of colorectal cancer screening, commented on this study for The ASCO Post. Although the...

Colorectal Cancer

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Young-Onset Colorectal Cancer Diagnoses Rising

Colorectal cancer is being increasingly diagnosed in persons younger than age 50, the age at which colorectal cancer screening is usually initiated. According to Elie Sutton, MD, of Mount Sinai West...

Oct

Today In Oncology

FDA Approves Talazoparib for Deleterious Germline BRCA-Mutated HER2-Negative Locally Advanced or Metastatic Breast Cancer

Study Finds Deep Learning Can Distinguish Recalled-Benign Mammogram Images From Malignant and Negative Cases

FDA Accepts New Drug Application, Grants Priority Review to Selinexor for Pentarefractory Multiple Myeloma

Small Study of Neoadjuvant Combination Checkpoint Blockade in High-Risk Stage III Melanoma

Opioid Use Following Video-Assisted Thoracoscopic Surgery or Open Resection in Early-Stage Lung Cancer

;

2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Young-Onset Colorectal Cancer Diagnoses Rising

FDA Approves Talazoparib for Deleterious Germline BRCA-Mutated HER2-Negative Locally Advanced or Metastatic Breast Cancer

Study Finds Deep Learning Can Distinguish Recalled-Benign Mammogram Images From Malignant and Negative Cases

FDA Accepts New Drug Application, Grants Priority Review to Selinexor for Pentarefractory Multiple Myeloma

Small Study of Neoadjuvant Combination Checkpoint Blockade in High-Risk Stage III Melanoma

Opioid Use Following Video-Assisted Thoracoscopic Surgery or Open Resection in Early-Stage Lung Cancer

Update on CML: Focus on Sequential Therapy, Treatment Discontinuation, and Monitoring

Results From ECHELON-2: Brentuximab Vedotin in CD30-Expressing Peripheral T-Cell Lymphoma

Neoadjuvant Paclitaxel With LCL161 in Localized Triple-Negative Breast Cancer

FDA Approves Expanded Use of Gardasil 9 to Include Individuals Aged 27 to 45

Adding Lomustine to Conventional Chemotherapy in Older Patients With AML Without Unfavorable Cytogenetics

Cathy Eng, MD, on Anal Squamous Cell Cancer: Management Strategies

Michael J. Overman, MD, and François Quenet, MD, on Colorectal Cancer: Results From the PRODIGE 7 Trial

Douglas W. Blayney, MD, on Quality Care: Better, Safer, Cheaper

Tony Mok, MD, on NSCLC: Results From the ARCHER 1050 Trial

Helena Margaret Earl, MBBS, PhD, on Early Breast Cancer: Results From the Persephone Trial